Shay Shemesh - May 10, 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Dev. & Ops. Officer
Signature
/s/ Shay Shemesh
Stock symbol
NVCT
Transactions as of
May 10, 2024
Transactions value $
$7,034
Form type
4
Date filed
5/13/2024, 08:47 AM
Previous filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $7.03K +1.11K +0.07% $6.32 1.49M May 10, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.19 to $6.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
F2 Includes 353,399 shares of restricted stock.